Phase Ib study of FOLFOXIRI plus ramucirumab as first-line treatment for patients with metastatic colorectal cancer.
Yosuke KitoHironaga SatakeHiroya TaniguchiTakeshi YamadaYoshiki HorieTaito EsakiTadamichi DendaHisateru YasuiNaoki IzawaToshiki MasuishiToshikazu MoriwakiKeita MoriKentaro YamazakiPublished in: Cancer chemotherapy and pharmacology (2020)
UMIN000023277.
Keyphrases